Metoclopramide and Extrapyramidal disorder - a phase IV clinical study of FDA data
We study 76,991 people who have side effects when taking Metoclopramide. Extrapyramidal disorder is found, especially among people who are female, 60+ old, have been taking the drug for 2 - 5 years, also take Reglan and have Indigestion.
The phase IV clinical study analyzes which people take Metoclopramide and have Extrapyramidal disorder. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
76,991 people reported to have side effects when taking Metoclopramide.
Among them, 14,572 people (18.93%) have Extrapyramidal disorder.
What is Metoclopramide?
Metoclopramide has active ingredients of metoclopramide hydrochloride. It is used in nausea. Currently, eHealthMe is studying from 77,443 Metoclopramide users.
What is Extrapyramidal disorder?
Extrapyramidal disorder (involuntary muscle spasms in the face and neck) is found to be associated with 1,517 drugs and 939 conditions by eHealthMe. Currently, we are studying 29,787 people who have Extrapyramidal disorder.
Number of Metoclopramide and Extrapyramidal disorder reports submitted per year:
Time on Metoclopramide when people have Extrapyramidal disorder *:
Gender of people who have Extrapyramidal disorder when taking Metoclopramide*:
Age of people who have Extrapyramidal disorder when taking Metoclopramide *:
Common drugs people take besides Metoclopramide *:
Common side effects people have besides Extrapyramidal disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metoclopramide and have Extrapyramidal disorder?Check whether Extrapyramidal disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Metoclopramide side effects by duration, gender and age:
- Metoclopramide side effects (77,443 reports)
Extrapyramidal disorder treatments and more:
- Extrapyramidal disorder (29,787 reports)
Common drugs associated with Extrapyramidal disorder:
- Metoclopramide: 14,572 reports
- Clopra: 14,572 reports
- Reglan: 4,988 reports
- Risperdal: 2,455 reports
- Risperidone: 1,824 reports
- Abilify: 1,248 reports
- Olanzapine: 1,206 reports
- Metoclopramide hydrochloride: 1,107 reports
- Haloperidol: 845 reports
- Aripiprazole: 739 reports
All the drugs that are associated with Extrapyramidal disorder:
- Extrapyramidal disorder (1,517 drugs)
Common conditions associated with Extrapyramidal disorder:
- Indigestion: 2,792 reports
- Schizophrenia: 1,935 reports
- Bipolar disorder: 1,205 reports
- Depression: 1,174 reports
- Attention deficit hyperactivity disorder: 526 reports
All the conditions that are associated with Extrapyramidal disorder:
- Extrapyramidal disorder (939 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Metoclopramide) and Metoclopramide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Paricalcitol and Magnesium Sulfate drug interaction - 5 seconds ago
- Epinephrine and Blood Glucose Fluctuation - 7 seconds ago
- Antivert and Muscle Spasms - 17 seconds ago
- Cresemba and Chills - 35 seconds ago
- Phytonadione and Oedema Aggravated - 49 seconds ago
- Fiasp and Dotarem drug interaction - 51 seconds ago
- Mirtazapine and Duoneb drug interaction - 59 seconds ago
- Isentress and Mesna drug interaction - a minute ago
- Sildenafil Citrate and Jardiance drug interaction - a minute ago
- Xarelto and Striverdi Respimat drug interaction - a minute ago